Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADME Study of [14C]Icosabutate in Healthy Males
NCT02373176Phase 1Completed
- Sponsor
- Pronova BioPharma
- Start
- Jul 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of icosabutate in hypertriglyceridemia, sponsored by Pronova BioPharma. Primary endpoints: Area under curve for total 14C labelled PRC-4016 in whole blood and plasma, Peak plasma concentration of 14C labelled PRC-4016 (icosabutate) and 1 more. Started Jul 2014; status: completed.
02
Drugs
icosabutate
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT02373176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373176.